Genetic testing has no place as a routine diagnostic test in sporadic and familial cases of Alzheimer's disease

Journal of the American Geriatrics Society

Volumn 52, Issue 12, 2004, Pages 2110-2113

  Van Der Cammen, Tischa J M ^a   Croes, Esther A ^a   Dermaut, Bart ^b   De Jager, Marie Claire ^a   Cruts, Marc ^b   Van Broeckhoven, Christine ^b   Van Duijn, Cornelia M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Alzheimer's disease; Diagnostic examination; Genetic testing; Sporadic versus familial cases

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; DIAGNOSTIC TEST; EARLY DIAGNOSIS; FAMILIAL DISEASE; GENETIC SCREENING; HUMAN; MEDICAL ETHICS; MEDICAL EXAMINATION; PHYSICIAN; RISK FACTOR; AGED; DECISION MAKING; EVIDENCE BASED MEDICINE; FEMALE; GENETIC PREDISPOSITION; GENETICS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DECISION MAKING; EVIDENCE-BASED MEDICINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS;

EID: 16644397563     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2004.52573.x     Document Type: Article

References (21)

1. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, DC: American Psychiatric Association, 1994.
2. McKhann G, Drachmann D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
3. Knopman DS, DeKosky ST, Cummings JL et al. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143-1153.
4. Finckh U, Muller-Thomsen T, Mann U et al. High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analysis of four different genes. Am J Hum Genet 2000;66:110-117.
5. Croes EA, Dermaut B, van der Cammen TJM et al. Genetic testing should not be advocated as a diagnostic tool in familial forms of dementia. Am J Hum Genet 2000;67:1033-1035.
6. Campion D, Dumanchin C, Hannequin D et al. Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 1999;65:664-670.
7. Hardy J. Amyloid, the presenilins and Alzheimer disease. Trends Neurosci 1997;20:154-159.
8. Alzheimer Disease and Frontotemporal Dementia Mutation Database [on-line]. Available at www.molgen.ua.ac.be/ADMutations/ Accessed August 25, 2004.
9. Cruts M, van Duijn CM, Backhovens H et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Molec Genet 1998;7:43-51.
10. Cruts M, Van Broeckhoven C. Presenilin mutations in Alzheimer's disease. Hum Mutat 1998;11:183-190.
11. Li Y-M, Xu M, Lai M-T et al. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 2000;405:689-694.
12. Nussbaum RL, Ellis CE. Genomic medicine. Alzheimer's disease and Parkinson's disease. N Engl J Med 2003;348:1356-1364.
13. Seshadri S, Drachman DA, Lippa CF. Apolipoprotein E ε4 allele and the lifetime risk of Alzheimer's disease-what physicians know, and what they should know. Arch Neurol 1995;52:1074-1079.
14. Corder EH, Saunder AM, Strittmatter WJ et al. Gene dosage of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
15. Dermaut B, Cruts M, Slooter AJ et al. The Glu318Gly substitution in presenilin 1 is not causally related to Alzheimer's disease. Am J Hum Genet 1999;64:290-292.
16. Marteau TM, Croyle RT. Psychological responses to genetic testing. BMJ 1998;316:693-696.
17. Mayeux R, Saunders AM, Shea S et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. N Engl J Med 1998;338:506-511.
18. Slooter AJ, Breteler MB, Ott A et al. APOE genotyping in differential diagnosis of Alzheimer's disease. Lancet 1996;348:334.
19. Journal of the American Geriatrics Society Ethics Committee. Genetic testing for late-onset Alzheimer's disease. J Am Geriatr Soc 2001;49:225-226.
20. Guttmacher AE, Collins FS. Welcome to the genomic era. N Engl J Med 2003;349:996-998.
21. Holtzman NA, Marteau TM. Will genetics revolutionize medicine? N Engl J Med 2000;343:141-144.